By targeting IL-10, miR-98 prevents HCC from spreading in HCC-conditioned tumor-associated macrophages (TAMs) (Li et al. 2018) and by targeting NIK, miR-98-5p prevents HBV-HCC cells from proliferating, migrating, and invading (Fei et al. 2020). Here, IL10 is linked to hepatocellular carcinoma.